XML 21 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 85.4 $ 69.1
Restricted cash 37.7 35.1
Accounts receivable 598.8 611.6
Prepaid expenses 42.3 34.5
Other current assets 122.7 91.5
Total current assets 886.9 841.8
Property and equipment, net 3,643.1 3,301.0
Operating lease right-of-use assets 203.7 208.5
Goodwill 1,284.0 1,281.3
Intangible assets, net 297.8 278.2
Other long-term assets 219.2 191.6
Total assets [1] 6,534.7 6,102.4
Current liabilities:    
Current portion of long-term debt 138.6 24.8
Current operating lease liabilities 26.3 24.1
Accounts payable 171.0 170.0
Accrued payroll 227.9 207.5
Accrued interest payable 38.6 42.6
Other current liabilities 238.6 187.4
Total current liabilities 841.0 656.4
Long-term debt, net of current portion 2,359.2 2,687.8
Long-term operating lease liabilities 189.7 196.1
Self-insured risks 138.6 131.8
Deferred income tax liabilities 105.2 87.0
Other long-term liabilities 51.8 46.1
Total liabilities [1] 3,685.5 3,805.2
Commitments and contingencies
Redeemable noncontrolling interests 56.5 42.0
Encompass Health shareholders’ equity:    
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 116,036,500 in 2024; 115,416,676 in 2023 1.2 1.2
Capital in excess of par value 1,847.0 1,787.0
Accumulated income 796.7 406.5
Treasury stock, at cost (15,261,136 shares in 2024 and 15,163,909 shares in 2023) (577.9) (547.2)
Total Encompass Health shareholders’ equity 2,067.0 1,647.5
Noncontrolling interests 725.7 607.7
Total shareholders’ equity 2,792.7 2,255.2
Total liabilities and shareholders’ equity [1] $ 6,534.7 $ 6,102.4
[1] Our consolidated assets as of December 31, 2024 and December 31, 2023 include total assets of variable interest entities of $208.1 million and $207.7 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2024 and December 31, 2023 include total liabilities of the variable interest entities of $45.0 million and $42.2 million, respectively. See Note 3, Variable Interest Entities.